Fluctuations in pO2 in irradiated human melanoma xenografts

Radiation Research

Volumn 165, Issue 1, 2006, Pages 16-25

  Brurberg, Kjetil G ^a   Thuen, Marte ^a   Ruud, Eise Beate M ^a   Rofstad, Einar K ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER RADIOTHERAPY; CELL STRAIN; CELL STRAIN A 07; CONTRAST ENHANCEMENT; ELECTRONIC SENSOR; EXTRACELLULAR SPACE; FEMALE; HUMAN; HUMAN CELL; IRRADIATION; MELANOMA; MICROENVIRONMENT; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN TENSION; PERFUSION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; TIME; TUMOR MICROENVIRONMENT; TUMOR XENOGRAFT; ANIMAL; BAGG ALBINO MOUSE; GAMMA RADIATION; METABOLISM; OXYGEN CONSUMPTION; RADIATION RESPONSE; TRANSPLANTATION; TUMOR CELL LINE;

ANIMALIA;

OXYGEN;

ANIMALS; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; GAMMA RAYS; HUMANS; MELANOMA; MICE; MICE, INBRED BALB C; OXYGEN; OXYGEN CONSUMPTION; RADIATION DOSAGE;

EID: 27944503067     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR3491.1     Document Type: Article

References (53)

1. P. Vaupel, Oxygenation of human tumors. Strahlenther. Onkol. 166, 377-386 (1990).
2. M. R. Horsman, Nicotinamide and other benzamide analogs as agents for overcoming hypoxic cell radiation resistance in tumours. Acta Oncol. 34, 571-587 (1995).
3. J. M. Brown, The hypoxic cell: A target for selective cancer therapy. Cancer Res. 59, 5863-5870 (1999).
4. H. Kimura, R. D. Braun, E. T. Ong, R. Hsu, T. W. Secomb, D. Papahadjopoulos, K. Hong and M. W. Dewhirst, Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. Cancer Res. 56, 5522-5528 (1996).
5. B. G. Wouters, S. A. Weppler, M. Koritzinsky, W. Landuyt, S. Nuyts, J. Theys, R. K. Chiu and P. Lambin, Hypoxia as a target for combined modality treatments. Eur. J. Cancer 38, 240-257 (2002).
6. R. M. Sutherland, Tumor hypoxia and gene expression - implications for malignant progression and therapy. Acta Oncol. 37, 567-574 (1998).
7. E. K. Rofstad, Microenvironment-induced cancer metastasis. Int. J. Radiat. Biol. 76, 589-605 (2000).
8. M. R. Horsman and J. Overgaard, Overcoming tumour radiation resistance resulting from acute hypoxia. Eur. J. Cancer 28, 717-718 (1992).
9. J. H. Kaanders, L. A. Pop, H. A. Marres, I. Bruaset, F. J. van den Hoogen, M. A. Merkx and A. J. van der Kogel, ARCON: Experience in 215 patients with advanced head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 52, 769-778 (2002).
10. T. P. Padera, B. R. Stoll, J. B. Tooredman, D. Capen, E. di Tomaso and R. K. Jain, Pathology: Cancer cells compress intratumour vessels. Nature 427, 695 (2004).
11. R. K. Jain, Determinants of tumor blood flow. A review. Cancer Res. 48, 2641-2658 (1988).
12. C. A. Znati, M. Rosenstein, Y. Boucher, M. W. Epperly, W. D. Bloomer and R. K. Jain, Effect of radiation on interstitial fluid pressure and oxygenation in a human tumor xenograft. Cancer Res. 56, 964-968 (1996).
13. P. Vaupel, F. Kallinowski and P. Okunieff, Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review. Cancer Res. 49, 6449-6465 (1989).
14. C. J. Gulledge and M. W. Dewhirst, Tumor oxygenation: A matter of supply and demand. Anticancer Res. 16, 741-750 (1996).
15. R. F. Kallman, The phenomenon of reoxygenation and its implications for fractionated radiotherapy. Radiology 105, 135-142 (1972).
16. F. Goda, J. A. O'Hara, E. S. Rhodes, K. J. Liu, J. F. Dunn, G. Bacic and H. M. Swartz, Changes of oxygen tension in experimental tumors after a single dose of X-ray irradiation. Cancer Res. 55, 2249-2252 (1995).
17. 2) during accelerated radiotherapy of head and neck carcinoma. Eur. J. Cancer 34, 856-861 (1998).
18. P. Stadler, H. J. Feldmann, C. Creighton, R. Kau and M. Molls, Changes in tumor oxygenation during combined treatment with split-course radiotherapy and chemotherapy in patients with head and neck cancer. Radiother. Oncol. 48, 157-164 (1998).
19. M. W. Dewhirst, H. Kimura, S. W. Rehmus, R. D. Braun, D. Papahadjopoulos, K. Hong and T. W. Secomb, Microvascular studies on the origins of perfusion-limited hypoxia. Br. J. Cancer 27, S247-S251 (1996).
20. 2 of R3230Ac tumors in Fischer-344 rats. Int. J. Radiat. Oncol. Biol. Phys. 42, 723-726 (1998).
21. R. D. Braun, J. L. Lanzen and M. W. Dewhirst, Fourier analysis of fluctuations of oxygen tension and blood flow in R3230Ac tumors and muscle in rats. Am. J. Physiol. 277, H551-H568 (1999).
22. B. M. Seddon, D. J. Honess, B. Vojnovic, G. M. Tozer and P. Workman, Measurement of tumor oxygenation: In vivo comparison of a luminescence fiber-optic sensor and a polarographic electrode in the p22 tumor. Radiat. Res. 155, 837-846 (2001).
23. R. D. Braun, J. L. Lanzen, S. A. Snyder and M. W. Dewhirst, Comparison of tumor and normal tissue oxygen tension measurements using OxyLite or microelectrodes in rodents. Am. J. Physiol. 280, H2533-H2544 (2001).
24. K. G. Brurberg, B. A. Graff and E. K. Rofstad, Temporal heterogeneity in oxygen tension in human melanoma xenografts. Br. J. Cancer 89, 350-356 (2003).
25. L. I. Cardenas-Navia, D. Yu, R. D. Braun, D. M. Brizel, T. W. Secomb and M. W. Dewhirst, Tumor-dependent kinetics of partial pressure of oxygen fluctuations during air and oxygen breathing. Cancer Res. 64, 6010-6017 (2004).
26. 2 fluctuations in human melanoma xenografts. Int. J. Radiat. Oncol. Biol. Phys. 58, 403-409 (2004).
27. E. K. Rofstad, S. H. Tunheim, B. Mathiesen, B. A. Graff, E. F. Halsør, K. Nilsen and K. Galappathi, Pulmonary and lymph node metastasis is associated with primary tumor interstitial fluid pressure in human melanoma xenografts. Cancer Res. 62, 661-664 (2002).
28. E. K. Rofstad and K. Måseide, Fraction of radiobiologically hypoxic cells in human melanoma xenografts measured by using single-cell survival, tumour growth delay and local tumour control as end points. Br. J. Cancer 78, 893-898 (1998).
29. E. K. Rofstad and K. Måseide, Radiobiological and immunohistochemical assessment of hypoxia in human melanoma xenografts: Acute and chronic hypoxia in individual tumours. Int. J. Radiat. Biol. 75, 1377-1393 (1999).
30. E. K. Rofstad, Hypoxia and reoxygenation in human melanoma xenografts. Int. J. Radiat. Oncol. Biol. Phys. 17, 81-89 (1989).
31. E. K. Rofstad, Orthotopic human melanoma xenograft model systems for studies of tumour angiogenesis, pathophysiology, treatment sensitivity and metastatic pattern. Br. J. Cancer 70, 804-812 (1994).
32. J. R. Griffiths and S. P. Robinson, The OxyLite: A fibre-optic oxygen sensor. Br. J. Radiol. 72, 627-630 (1999).
33. B. A. Graff, Y. Kvinnsland, A. Skretting and E. K. Rofstad, Intratumour heterogeneity in the uptake of macromolecular therapeutic agents in human melanoma xenografts. Br. J. Cancer 88, 291-297 (2003).
34. I. C. Benjaminsen, B. A. Graff, K. G. Brurberg and E. K. Rofstad, Assessment of tumor blood perfusion by high-resolution dynamic contrast-enhanced MRI: A preclinical study of human melanoma xenografts. Magn. Reson. Med. 52, 269-276 (2004).
35. E. K. Rofstad, E. Steinsland, O. Kaalhus, Y. B. Chang, B. Høvik and H. Lyng, Magnetic resonance imaging of human melanoma xenografts in vivo: Proton spin-lattice and spin-spin relaxation times versus fractional tumour water content and fraction of necrotic tumour tissue. Int. J. Radiat. Biol. 65, 387-401 (1994).
36. H. Lyng, G. A. Dahle, O. Kaalhus, A. Skretting and E. K. Rofstad, Measurement of perfusion rate in human melanoma xenografts by contrast-enhanced magnetic resonance imaging. Magn. Reson. Med. 40, 89-98 (1998).
37. K. Hittmair, G. Gomiscek, K. Langenberger, M. Recht, H. Imhof and J. Kramer, Method for the quantitative assessment of contrast agent uptake in dynamic contrast-enhanced MRI. Magn. Reson. Med. 31, 567-571 (1994).
38. B. A. Graff, L. Vangberg and E. K. Rofstad, Quantitative assessment of uptake and distribution of iron oxide particles (NC100150) in human melanoma xenografts by contrast-enhanced MRI. Magn. Reson. Med. 51, 727-735 (2004).
39. S. Kety, Theory of blood-tissue exchange and its application to measurements of blood flow. Methods Med. Res. 8, 228-236 (1960).
40. B. A. Graff, I. C. Benjaminsen, K. G. Brurberg, E. B. M. Ruud and E. K. Rofstad, Comparison of tumor blood perfusion assessed by dynamic contrast-enhanced MRI with tumor blood supply assessed by invasive imaging. J. Magn. Reson. Imaging 21, 272-281 (2005).
41. J. V. Gaustad, I. C. Benjaminsen, B. A. Graff, K. G. Brurberg, E. B. M. Ruud and E. K. Rofstad, Intratumor heterogeneity in blood perfusion in orthotopic human melanoma xenografts assessed by dynamic contrast-enhanced MRI. J. Magn. Reson. Imaging 21, 792-800 (2005).
42. B. A. Graff, I. C. Benjaminsen, E. A. Melås, K. G. Brurberg and E. K. Rofstad, Changes in intratumor heterogeneity in blood perfusion in intradermal human melanoma xenografts during tumor growth assessed by DCE-MRI. Magn. Reson. Imaging, in press.
43. P. S. Tofts, Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J. Magn. Reson. Imaging 7, 91-101 (1997).
44. P. S. Tofts, G. Brix, D. L. Buckley, J. L. Evelhoch, E. Henderson, M. V. Knopp, H. B. Larsson, T. Y. Lee, N. A. Mayr and R. M. Weisskoff, Estimating kinetic parameters from dynamic contrast-enhanced T -weighted MRI of a diffusable tracer: Standardized quantities and symbols. J. Magn. Reson. Imaging 10, 223-232 (1999).
45. H. Yamaura and T. Matsuzawa, Tumor regrowth after irradiation: An experimental approach. Int. J. Radiat. Biol. 35, 201-219 (1979).
46. D. J. Chaplin, R. E. Durand and P. L. Olive, Acute hypoxia in tumors: Implications for modifiers of radiation effects. Int. J. Radiat. Oncol. Biol. Phys. 12, 1279-1282 (1986).
47. D. R. Collingridge, W. K. Young, B. Vojnovic, P. Wardman, E. M. Lynch, S. A. Hill and D. J. Chaplin, Measurement of tumor oxygenation: A comparison between polarographic needle electrodes and a time-resolved luminescence-based optical sensor. Radiat. Res. 147, 329-334 (1997).
48. K. L. Bennewith, J. A. Raleigh and R. E. Durand, Orally administered pimonidazole to label hypoxic tumor cells. Cancer Res. 62, 6827-6830 (2002).
49. E. O. Pettersen and H. Wang, Radiation-modifying effect of oxygen in synchronized cells pre-treated with acute or prolonged hypoxia. Int. J. Radiat. Biol. 70, 319-326 (1996).
50. F. Zölzer and C. Streffer, Increased radiosensitivity with chronic hypoxia in four human tumor cell lines. Int. J. Radiat. Oncol. Biol. Phys. 54, 910-920 (2002).
51. R. A. Cairns, T. Kalliomäki and R. P. Hill, Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors. Cancer Res. 61, 8903-8908 (2001).
52. R. A. Cairns and R. P. Hill, Acute hypoxia enhances spontaneous lymph node metastasis in an orthotopic murine model of human cervical carcinoma. Cancer Res. 64, 2054-2061 (2004).
53. E. K. Rofstad, B. Mathiesen and K. Galappathi, Increased metastatic dissemination in human melanoma xenografts after subcurative radiation treatment: Radiation-induced increase in fraction of hypoxic cells and hypoxia-induced up-regulation of urokinase-type plasminogen activator receptor. Cancer Res. 64, 13-18 (2004).